Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.250
+0.280 (9.43%)
Nov 22, 2024, 4:00 PM EST - Market closed

Fulcrum Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-17.91-97.34-109.87-80.85-70.82-82.68
Upgrade
Depreciation & Amortization
1.732.172.412.522.382.05
Upgrade
Asset Writedown & Restructuring Costs
-----25.59
Upgrade
Loss (Gain) From Sale of Investments
-4.78-5.990.150.67-0.07-
Upgrade
Stock-Based Compensation
15.5314.813.3511.077.354.22
Upgrade
Other Operating Activities
---0---
Upgrade
Change in Accounts Receivable
-3.08-0.313.41-1.11-2.53-
Upgrade
Change in Accounts Payable
0.29-0.85-1.180.971.770.8
Upgrade
Change in Unearned Revenue
-0.33-0.93-3.78-13.177.8810
Upgrade
Change in Other Net Operating Assets
-0.06-2.52-1.551.410.380.52
Upgrade
Operating Cash Flow
-8.62-90.97-97.05-78.48-53.66-39.48
Upgrade
Capital Expenditures
-0.12-0.51-1.96-1.71-1.34-0.94
Upgrade
Investment in Securities
48.45-36.1814.38-127.96-55.8-
Upgrade
Investing Cash Flow
48.32-36.6912.41-129.67-57.14-0.94
Upgrade
Long-Term Debt Repaid
----0.02-0.05-0.05
Upgrade
Net Debt Issued (Repaid)
----0.02-0.05-0.05
Upgrade
Issuance of Common Stock
2.95118.1284.32186.5371.3864.42
Upgrade
Other Financing Activities
-----0.19-0.03
Upgrade
Financing Cash Flow
2.95118.1284.32186.5171.1364.34
Upgrade
Net Cash Flow
42.66-9.54-0.31-21.64-39.6623.92
Upgrade
Free Cash Flow
-8.74-91.47-99.01-80.19-55-40.43
Upgrade
Free Cash Flow Margin
-10.81%-3261.07%-1561.23%-418.47%-623.34%-
Upgrade
Free Cash Flow Per Share
-0.14-1.49-2.20-2.27-2.17-3.66
Upgrade
Cash Interest Paid
----00.01
Upgrade
Levered Free Cash Flow
-4.82-56.72-58.12-47.54-24.98-41.47
Upgrade
Unlevered Free Cash Flow
-4.82-56.72-58.12-47.54-24.98-41.47
Upgrade
Change in Net Working Capital
4.214.021.848.75-11.39-5.84
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.